Nachrichten

BEIJING, AUGUST 24, 2021 - Lepu Medical Technology (Beijing) Co., Ltd. (“Lepu Medical”), a leading global company specialized in developing, manufacturing and marketing high-tech medical devices and equipment, today announced that its Sterile Spritze für Einweg-Linie Erhielt die CE-Kennzeichnung für den allgemeinen Gebrauch, einschl ießlich der Lieferung verschiedener COVID-19 Impfstoffe.

Das CE-Zeichen weist darauf hin, dass die sterile Spritze für den einmaligen Gebrauch von Lepu Medical den Sicherheits-und Leistungs standards der Europäischen Union (EU) für die Verwendung durch Angehörige der Gesundheits berufe zur allgemeinen Flüssigkeits aspiration und-injektion entspricht, wodurch sie für den profession ellen Kauf in der gesamten EU und anderen Ländern verfügbar sind Länder, die das CE-Zeichen erkennen.

Lepu Medical’s Sterile Spritze für Einweg-Linie has received CE Mark approval at a time of high-demand for needles suitable to vaccinate populations against the COVID-19 pandemic.  Lepu Medical’s syringe series offers a variety of single-use needles for many applications, including various COVID-19 vaccines. The line includes both Luer Lock and Lock Slip syringes, a clear barrel, plunger, plunger stopper, needle, and cap. Lepu Medical’s syringe series offers a higher resistance to breakage in single-use, and latex-free pistons. The total graduated capacity of all models of syringes is 1mL, with a range of needle sizes to meet a variety of injection and COVID-19 vaccine needs, each distinguished by the color of the needle hub.

Designed to meet a variety of injection needs, Lepu Medical’s Sterile Syringe For Single-Use brings improved safety to patients and doctors with its clear barrel for convenient control of foreign substances. The Sterile Syringe For Single-Use is intended only for one-time use by  healthcare professionals who have received training on medical injection techniques. Injection and vaccine administrators can refer to the Lepu Medical professional manual before use for a full understanding of the device instructions, warnings and precautions.

Zusätzlich zur sterilen Spritze für den einmaligen Gebrauch hat Lepu Medical verschiedene medizinische Hilfsmittel zur COVID-19 prävention und-kontrolle bereit gestellt, darunter das SARS-CoV-2 Antigen-Schnelltest-Kit für Selbst tests und das SARS-CoV-2 Antikörper-Test-Kit für Tests im Gesundheits wesen. Lepu Medical bietet auch COVID-19 diagnostische Lösungen wie Nukleinsäure produkte und-lösungen zur Bereitstellung von Standard tests für die Diagnose von COVID-19 sowie Antikörper test produkte zur Überwachung des Niveaus der COVID-19 immunität an. Zu den weiteren COVID-19 Produkten und Lösungen von Lepu Medical gehören Proben entnahme kits, manuelle Proben extraktion skits, automat isierte Proben extraktoren und Echtzeit-PCR-Systeme für die klinische Standard diagnostik von Nukleinsäure.

As of August 2021, the number of global daily doses of COVID-19 vaccines continues to rise, driving demand for vaccines and vaccination supplies. According to published statistics, by the end of 2020, major governments had placed purchases for over nine billion vaccine units. With the onset of the Delta virus, vaccination rates are ramping up and the expected number of vaccine units is increasing. Government officials and medical professionals across the globe from Israel, France, Germany, the U.S, the United Arab Emirates, Bahrain, the United Kingdom, Switzerland, Cambodia and others are proposing and actively preparing for the third dose of the COVID-19 vaccination to strengthen pandemic prevention and control efforts. With the CE Mark approval for the Sterile Syringe For Single-Use, Lepu Medical will continue to proactively seek qualified partners to support the availability of reliable vaccine supplies across the globe, and assist with COVID-19 management and continuation of general medical practices.